Updated at 5:25 p.m.
Senate and House lawmakers unveiled legislation Tuesday that would require brand-name drugmakers to pay rebates to Medicare for drugs used by some of the program’s low-income and disabled beneficiaries.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF—an independent source of health policy research, polling, and journalism. Learn more about KFF.Some elements may be removed from this article due to republishing restrictions. If you have questions about available photos or other content, please contact NewsWeb@kff.org.